Drug
Levonorgestrel 1.5mg
Levonorgestrel 1.5mg is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
2(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (100.0%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_2
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
NCT05695352
completedphase_2
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
NCT03614494
completed
A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg
NCT04058873
Clinical Trials (3)
Showing 3 of 3 trials
NCT05695352Phase 2
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
NCT03614494Phase 2
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
NCT04058873
A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3